WO2011054997A3 - Anticuerpo monoclonal que reconoce la proteína gapdh de candida famata - Google Patents
Anticuerpo monoclonal que reconoce la proteína gapdh de candida famata Download PDFInfo
- Publication number
- WO2011054997A3 WO2011054997A3 PCT/ES2010/070718 ES2010070718W WO2011054997A3 WO 2011054997 A3 WO2011054997 A3 WO 2011054997A3 ES 2010070718 W ES2010070718 W ES 2010070718W WO 2011054997 A3 WO2011054997 A3 WO 2011054997A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- monoclonal antibody
- candida famata
- gapdh protein
- recognises
- antibody
- Prior art date
Links
- 241000235036 Debaryomyces hansenii Species 0.000 title abstract 4
- 101100447432 Danio rerio gapdh-2 gene Proteins 0.000 title 1
- 101150112014 Gapdh gene Proteins 0.000 title 1
- 210000004408 hybridoma Anatomy 0.000 abstract 3
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 abstract 2
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 abstract 2
- 241000222122 Candida albicans Species 0.000 abstract 1
- 206010007134 Candida infections Diseases 0.000 abstract 1
- 201000003984 candidiasis Diseases 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56961—Plant cells or fungi
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
- G01N2333/39—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
- G01N2333/40—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts from Candida
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La presente invención se refiere a un anticuerpo monoclonal, o cualquiera de sus fragmentos, obtenido del hibridoma depositado con nº de acceso ECACC09042201. Dicho anticuerpo es capaz de reconocer la proteína GAPDH de Candida famata. Asimismo, la presente invención se refiere a dicho hibridoma, al epítopo de la proteína GAPDH de Candida famata reconocido por dicho anticuerpo monoclonal, a los usos de hibridoma, anticuerpo o epítopo, o al kit que los comprende. Además, la presente invención se refiere a un método para la detección de Candida famata o para la determinación de la evolución de candidiasis producida por dicho microorganismo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ESP200930966 | 2009-11-06 | ||
ES200930966A ES2359203B9 (es) | 2009-11-06 | 2009-11-06 | Anticuerpo monclonal que reconoce la proteína gapdh de candida famata. |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011054997A2 WO2011054997A2 (es) | 2011-05-12 |
WO2011054997A3 true WO2011054997A3 (es) | 2011-06-30 |
Family
ID=43927601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/ES2010/070718 WO2011054997A2 (es) | 2009-11-06 | 2010-11-05 | Anticuerpo monoclonal que reconoce la proteína gapdh de candida famata |
Country Status (2)
Country | Link |
---|---|
ES (1) | ES2359203B9 (es) |
WO (1) | WO2011054997A2 (es) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000052053A1 (en) * | 1999-03-01 | 2000-09-08 | Research And Development Institute, Inc. | Antibodies against phosphomannan that are protective against candidiasis |
-
2009
- 2009-11-06 ES ES200930966A patent/ES2359203B9/es not_active Expired - Fee Related
-
2010
- 2010-11-05 WO PCT/ES2010/070718 patent/WO2011054997A2/es active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000052053A1 (en) * | 1999-03-01 | 2000-09-08 | Research And Development Institute, Inc. | Antibodies against phosphomannan that are protective against candidiasis |
Non-Patent Citations (1)
Title |
---|
DELGADO M.L. ET AL: "Candida albicans TDH3 gene promotes secretion of internal invertase when expressed in Saccharomyces cerevisiae as a glyceraldehyde-3-phosphate dehydrogenase-invertase fusion protein", YEAST, vol. 20, no. 8, June 2003 (2003-06-01), pages 713 - 722 * |
Also Published As
Publication number | Publication date |
---|---|
ES2359203B9 (es) | 2013-02-19 |
ES2359203B1 (es) | 2012-06-21 |
ES2359203A1 (es) | 2011-05-19 |
WO2011054997A2 (es) | 2011-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010046775A3 (en) | Methods for producing antibodies from plasma cells | |
WO2010042562A3 (en) | Muc1* antibodies | |
WO2013037484A8 (en) | ANTI-αβTCR ANTIBODY | |
WO2017132627A3 (en) | Screening methods for identifying antibodies that bind cell surface epitopes | |
NZ591541A (en) | Pcsk9 antagonists | |
WO2004072266A3 (en) | Antibody affinity engineering by serial epitope-guided complementarity replacement | |
WO2010121093A3 (en) | Humanized antibody compositions and methods for binding lysophosphatidic acid | |
WO2009136382A3 (en) | Antibodies to receptor of advanced glycation end products (rage) and uses thereof | |
NZ587198A (en) | Monoclonal antibodies against the rgm a protein and uses thereof | |
WO2009052400A8 (en) | Antibodies that bind to mammalian ngal and uses thereof | |
IL202232A (en) | A method of making a human antibody derived from a rabbit parent antibody that binds to a desired antigen as well as a human antibody or fragment thereof produced by this method | |
IN2012DN03911A (es) | ||
WO2009135181A3 (en) | Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation | |
JP2010513228A5 (es) | ||
WO2009128963A3 (en) | Cross-neutralizing human monoclonal antibodies to sars-cov and methods of use thereof | |
CL2010000470A1 (es) | Anticuerpo que se une a efrina-b2 que comprende la region variable de la cadena liviana y pesada bvr-l1, hvr-l2, hvr-h1, hvr-h2 y hvr-h3; polinucleotido que codifica dicho anticuerpo; vector y celula huesped que comprende al polinucleotido; metodo para elaborar el anticuerpo, detectar efrina-b2; y uso de dicho anticuerpo. | |
WO2007110678A3 (en) | Neutralizing antibodies and methods of use thereof | |
WO2009048537A3 (en) | Humanized antibody | |
JP2010509937A5 (es) | ||
WO2006135527A3 (en) | Methods for the selection of aptamers | |
NZ595863A (en) | Antibodies to egfl7 and methods for their use | |
WO2008065384A3 (en) | Antibodies specific for the complex of interleukin-6 and the interleukin-6 receptor | |
WO2007001895A3 (en) | Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase | |
WO2012175602A3 (en) | Elisa for calprotectin | |
WO2008052108A3 (en) | Methods for use in human-adapting monoclonal antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10827948 Country of ref document: EP Kind code of ref document: A2 |